Ministry of Trade, Industry and Energy Announcement 2020-521, we were selected as industrial fusion and a leading company & product for cylinder pumps in 2020, and were invited to the awarding ceremony on December 16th.

AACPi is the first and only technology that can prepare anticancer (injection) drugs by machine like factory automation equipment with the cylinder cartridge, the core technology of cylinder pump and

Injectable preparation and infusion integrated APIS in ward and ICU, the first blood transfusion pump (BTP) that allows blood transfusion by machine at accident sites, ambulances, and emergency helicopters, PCA pump for self-pain control and Portable Ambulatory pump, Insulin pump, etc. These are fundamentally reduced medical accidents by reducing human errors by linking Anyfusion Platform technology with HIS, the ICT technology of the IT industry and It is a smart system that transmits real-time drug injection, situation and status to medical staff, which was inherently impossible of the drug injection pump. Leading the transformation of the medical environment with a smart system that integrates the analog-level business form that checks the status in real time or from time to time to IoT technology, as a technology that combines S/W technology with the core source technology of H/W, it is a leading company in the field of medicine and liquid injection in the medical industry. It is believed that the selection of this project will provide momentum.

Although the development task of intelligent pharmaceutical injection pump, which is a full-cycle medical device development project of the ministry, was rejected in, We have been selected for the Shinchon Severance IoT platform project of a cross-ministerial task and lead the development of intelligent pharmaceutical injection pumps. Although we were eliminated from innovative medical device companies and devices managed by the Ministry of Welfare and Food and Drug Administration, We have been selected as a leading national convergence company by the Ministry of Trade, Industry and Energy with the same purpose and effect that have no interest in medical insurance and we selected the anticancer (injection) formulation automation system development task as a BIG3 task by the Ministry of Small and Medium Ventures, which provides full-cycle support from the beginning to the detailed part. 

In two years, we will have developed an automated device for HIS-linked anticancer (injection) preparation, an IoT system, and an Anyfusion pump built with a bar code scanner, and have been able to lead the launch.

In addition, we will lead the development market from the ward and ICU (intensive care unit) injection formulation automation and injection integrated APIS system and derive results that meet the cause and purpose of a leading national industrial convergence company in the medical industry.

We will become a company that leads innovation and convergence in the global market as well as in Korea (national) rather than companies selected for cross-ministerial tasks and companies selected for innovative medical devices.

Thank you to everyone and everyone involved in the selection.